No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
AU Stock MarketDetailed Quotes
PTX Prescient Therapeutics Ltd
- 0.038
- -0.001-2.56%
20min DelayMarket Closed Jun 28 16:00 AET
30.60MMarket Cap-3800P/E (Static)
0.039High0.038Low1.26MVolume0.039Open0.039Pre Close47.89KTurnover0.10552wk High0.18%Turnover Ratio805.32MShares0.03852wk Low-0.01EPS TTM26.16MFloat Cap78409.237Historical HighLossP/E (Static)688.51MShs Float0.022Historical Low-0.01EPS LYR2.56%Amplitude--Dividend TTM1.36P/B1Lot Size--Div YieldTTM
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
We're Hopeful That Prescient Therapeutics (ASX:PTX) Will Use Its Cash Wisely
Prescient Therapeutics Receives AU$2.4 Million R&D Tax Rebate; Shares Down 4%
Here's Why We're Not Too Worried About Prescient Therapeutics' (ASX:PTX) Cash Burn Situation
Prescient Therapeutics (ASX:PTX) Is In A Good Position To Deliver On Growth Plans
Prescient Therapeutics (ASX:PTX) Shareholders Have Earned a 31% CAGR Over the Last Three Years
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
%Chg